Science Explorer Back to mapMap

Most cited papers in Sarcoidosis and Beryllium Toxicity Research

Sarcoidosis and Beryllium Toxicity Research

What are the most cited papers in Sarcoidosis and Beryllium Toxicity Research?

The most cited paper in Sarcoidosis and Beryllium Toxicity Research is "2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides" (J. Charles Jennette et al., 2012), with 6,681 citations. Next come "Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop" (4,424) and "Idiopathic pulmonary fibrosis" (2,068).

Showing 50 of 99 papers. Every paper with more than 505 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides J. Charles Jennette et al. · Arthritis & Rheumatism Open access 8 Oct 2012 6,681
2 Standardization of Uveitis Nomenclature for Reporting Clinical Data. Results of the First International Workshop Douglas A. Jabs, Robert Burton Nussenblatt, James Todd Rosenbaum · American Journal of Ophthalmology Open access 19 Jul 2005 4,424
3 Idiopathic pulmonary fibrosis Luca Richeldi, Harold R. Collard, Mark G. Jones · The Lancet 30 Mar 2017 2,068
4 Sarcoidosis Michael C. Iannuzzi, Benjamin A. Rybicki, Alvin S. Teirstein · New England Journal of Medicine 21 Nov 2007 1,973
5 The American College of Rheumatology 1990 criteria for the classification of wegener's granulomatosis Randi Y. Leavitt, Anthony S. Fauci, Daniel A. Bloch et al. · Arthritis & Rheumatism Aug 1990 1,964
6 Clinical Characteristics of Patients in a Case Control Study of Sarcoidosis Robert Phillip Baughman, Alvin S. Teirstein, Marc A. Judson et al. · American Journal of Respiratory and Critical Care Medicine Nov 2001 1,825
7 Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy Moisés Selman, Talmadge E. King, Annie Pardo · Annals of Internal Medicine 16 Jan 2001 1,814
8 CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis Julian David Gillmore et al. · New England Journal of Medicine Open access 26 Jun 2021 1,751
9 Collaborative Learning: Cognitive and Computational Approaches Ann C. Jones · Computers & Education Aug 2000 1,502
10 HRS Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis David H. Birnie, William H. Sauer, Frank Matthias Bogun et al. · Heart Rhythm 9 May 2014 1,492
11 Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report Harold R. Collard et al. · American Journal of Respiratory and Critical Care Medicine 14 Jun 2016 1,486
12 Goodpasture syndrome during the course of a Schönlein-Henoch purpura Luis O. Carreras, Rafael Poveda, Jordi Bas et al. · American Journal of Kidney Diseases May 2002 1,475
13 Anti-Neutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase in Patients with Systemic Vasculitis and Idiopathic Necrotizing and Crescentic Glomerulonephritis Ronald J. Falk, J. Charles Jennette · New England Journal of Medicine 23 Jun 1988 1,440
14 CLINICAL STUDIES WITH AN ARTICULAR INDEX FOR THE ASSESSMENT OF JOINT TENDERNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS Dorothy M. Ritchie, James A. Boyle, John M. Mcinnes et al. · QJM Jul 1968 1,351
15 Incidence and Prevalence of Idiopathic Pulmonary Fibrosis Ganesh Raghu, Derek A. Weycker, John Edelsberg et al. · American Journal of Respiratory and Critical Care Medicine 30 Jun 2006 1,326
16 ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Gary W. Hunninghake, Ulrich Costabel, Masaru Ando et al. · PubMed Sep 1999 1,310
17 Sarcoidosis Lee Scott Newman, Cecile Stephanie Rose, Lisa A. Maier · New England Journal of Medicine 24 Apr 1997 1,241
18 The Spectrum of Vasculitis Anthony S. Fauci, BARTON F. HAYNES, PAUL KATZ · Annals of Internal Medicine Open access Nov 1978 1,210
19 Acute Exacerbations of Idiopathic Pulmonary Fibrosis Harold R. Collard et al. · American Journal of Respiratory and Critical Care Medicine Open access 21 Jun 2007 1,139
20 Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy Peter Myles George, Athol Umfrey Wells, Gisli R. Jenkins · The Lancet Respiratory Medicine Open access 15 May 2020 1,129
21 Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline Elliott D. Crouser et al. · American Journal of Respiratory and Critical Care Medicine Open access Apr 2020 1,095
22 Sarcoidosis Dominique Valeyre, Antje Prasse, Hilario Nunès et al. · The Lancet 30 Sep 2013 1,090
23 Churg-Strauss Syndrome Clinical Study and Long-Term Follow-Up of 96 Patients Loı̈c Guillevin, Pascal Cohen, M. Gayraud et al. · Medicine 1999 1,077
24 Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper David A. Lynch, Nicola Sverzellati, William David Travis et al. · The Lancet Respiratory Medicine Open access 15 Nov 2017 1,042
25 Racial Differences in Sarcoidosis Incidence: A 5-Year Study in a Health Maintenance Organization Benjamin A. Rybicki, Marcie L. Major, John Popovich et al. · American Journal of Epidemiology Feb 1997 1,024
26 Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice Hong Xiao, Peter Heeringa, Peiqi Hu et al. · Journal of Clinical Investigation Open access Oct 2002 1,007
27 Idiopathic Pulmonary Fibrosis Thomas J Gross, Gary W. Hunninghake · New England Journal of Medicine 16 Aug 2001 975
28 CARD15 mutations in Blau syndrome Corinne Miceli‐Richard, Suzanne Lesage, Michel Rybojad et al. · Nature Genetics 27 Aug 2001 973
29 Pulmonary sarcoidosis Paolo Spagnolo, Giulio Rossi, Rocco Trisolini et al. · The Lancet Respiratory Medicine 3 Apr 2018 955
30 Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review John Woodside Hutchinson, Andrew Fogarty, Richard C. Hubbard et al. · European Respiratory Journal ReviewOpen access 14 May 2015 955
31 The Five-Factor Score Revisited Loı̈c Guillevin, Christian Pagnoux, Raphaèle Séror et al. · Medicine 31 Dec 2010 954
32 Causes and frequency of blindness in patients with intraocular inflammatory disease. Aniki Rothová, M S Suttorp-van Schulten, W F Treffers et al. · British Journal of Ophthalmology Open access Apr 1996 913
33 Sweet's syndrome – a comprehensive review of an acute febrile neutrophilic dermatosis Philip R Cohen · Orphanet Journal of Rare Diseases Open access 26 Jul 2007 883
34 Interstitial lung disease guideline Athol Umfrey Wells, Nik Hirani · Thorax Open access 29 Aug 2008 869
35 Predicting Survival in Idiopathic Pulmonary Fibrosis Talmadge E. King, Janet Austin Tooze, Marvin I. Schwarz et al. · American Journal of Respiratory and Critical Care Medicine Oct 2001 863
36 T-cell subsets (Th1 versus Th2) Sergio Romagnani · Annals of Allergy Asthma & Immunology Jul 2000 831
37 Manifestations of sarcoidosis Robert L. Mayock, Pierre Bertrand, Claire E. Morrison et al. · The American Journal of Medicine Jul 1963 807
38 A Case Control Etiologic Study of Sarcoidosis Lee Scott Newman et al. · American Journal of Respiratory and Critical Care Medicine 7 Sep 2004 804
39 Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome Jin Woo Song, Sang‐Bum Hong, Cheong-Su Lim et al. · European Respiratory Journal Open access Jul 2010 801
40 Sarcoidosis of the heart William Clifford Roberts, Hugh A. McAllister, Victor J. Ferrans · The American Journal of Medicine Jul 1977 789
41 Tetracyclines: Nonantibiotic properties and their clinical implications Allen N. Sapadin, Raúl Fleischmajer · Journal of the American Academy of Dermatology 27 Jan 2006 775
42 Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis Harold R. Collard, Talmadge E. King, Becki Bucher Bartelson et al. · American Journal of Respiratory and Critical Care Medicine 3 Jun 2003 768
43 Spectrum of Fibrotic Lung Diseases Marlies S Wijsenbeek, Vincent Cottin · New England Journal of Medicine 2 Sep 2020 748
44 Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis E. Christiaan Hagen, Mohamed R. Daha, J. Hermans et al. · Kidney International Open access Mar 1998 747
45 Central nervous system sarcoidosisdiagnosis and management John Zajicek · QJM Feb 1999 745
46 Sarcoidosis and Its Neurological Manifestations Barney J. Stern, Allan Krumholz, C. Johns et al. · Archives of Neurology Sep 1985 719
47 A STUDY OF SARCOIDOSIS WARFIELD T. LONGCOPE, DAVID G. PREIMAN · Medicine Feb 1952 719
48 Erdheim-Chester Disease Clinical and Radiologic Characteristics of 59 Cases Catherine Veyssier-Belot, P. Cacoub, Dominique Caparros-Lefebvre et al. · Medicine May 1996 712
49 PROSPECTIVE STUDY OF RADIOIMMUNOASSAY FOR ANTIBODIES AGAINST NEUTROPHIL CYTOPLASM IN DIAGNOSIS OF SYSTEMIC VASCULITIS CarolineO.S. Savage, Scott P. Jones, Christopher G. Winearls et al. · The Lancet Jun 1987 711
50 Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosis Ron Blankstein, Michael Thomas Osborne, Masanao Naya et al. · Journal of the American College of Cardiology Open access 16 Oct 2013 707

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.